1) Malignant ascites/Gastric cancer
癌性腹水/胃癌
2) ascites of gastric cancer
胃癌腹水
1.
Objective:To explore the effect of exosomes from ascites of gastric cancer patients on the function of macrophage.
结果:胃癌腹水中的外泌体对外周血来源巨噬细胞杀伤A549肺癌及MNK45胃癌细胞活性具有显著抑制作用,能显著抑制巨噬细胞对荧光细菌的吞噬率。
3) malignant ascites
癌性腹水
1.
Clinical study on hyperthermic peritoneal perfusion with oxaliplatin plus systemic chemotherapy for senile patients with malignant ascites;
腹腔热灌注化疗联合全身化疗治疗老年癌性腹水的临床研究
2.
In vitro immunosuppressive effects of malignant ascites from advanced gastrointestinal cancer patients on immune function of dendritic cells;
晚期胃肠道肿瘤癌性腹水对树突状细胞的抑制效应研究
3.
Objective To establish a nude mouse model of malignant ascites with human ovarian carcinoma cell line OVCAR3 which highly expresses VEGF and evaluate the therapeutic of Avastin combined with cisplan.
结论Avastin联合细胞毒药物的生物化疗治疗模式有望成为治疗癌性腹水的一种新方法。
5) malignant effusion
癌性胸腹水
1.
Tumor infiltration lymphocytes in the treatment of 60 cases of malignant effusion;
自体肿瘤浸润淋巴细胞治疗60例癌性胸腹水疗效观察
补充资料：乳糜性腹水
乳糜性腹水
chyloperitoneum
主要由丝虫病肉芽肿、淋巴结结核、肿瘤、外伤或术后瘢痕等阻塞或压迫胸导管与乳糜池引起的腹水，腹水呈乳白色。临床少见，可分为急性和慢性，晚期症状为消瘦、低蛋白血症、营养不良及全身衰竭等。对病因进行治疗。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条